ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports

December 1, 2020

The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices, and explore new ways to apply evidence in a drive toward a health system that can achieve fair prices and fair access for all.

“Over the past 14 years, ICER has dedicated itself to catalyzing more transparent public dialogue on value and to support evidence-based pricing and access,” said Steven D. Pearson, MD, MSc, ICER’s President. “Not only will ICER Analytics help people search and sort through our reports, but it will also make everything that we do more customizable and actionable. Those who want to insert their own evidence; who want to use the backbone of an ICER economic model to make a customized argument for value with a client or a negotiating partner; who want to compare quickly their own prices to the prices at different cost-effectiveness thresholds or using alternative measures to the QALY — all will find this now possible” Find out more about ICER Analytics™ here.

Share This Story!